Are you a new member? Sign up now
Login area
| Sign up
Let us help you
Read about the latest topics.
Read about the latest topics.
Clinical Trials
A. Approval of Clinical Trials in Lebanon
This section has been developed for individuals and organizations involved in health-related research with human participants. In particular, this document is intended to provide guidance to design and carry out health research studies to provide guidance on the requirements of the Lebanese Ministry of Public Health to approve a clinical trial in Lebanon.
This section has been developed for individuals and organizations involved in health-related research with human participants. In particular, this document is intended to provide guidance to design and carry out health research studies to provide guidance on the requirements of the Lebanese Ministry of Public Health to approve a clinical trial in Lebanon.
- Minister Decree No.1159/1 Date 23/6/2014 Concerning Clinical Trial Regulations
- Final Annex 3
- Final Annex 4
- Clinical Trial Evaluation Report
B. Authorization of Institutional Review Boards (IRBs)/Research Ethics Commitees (RECs)
This section has been developed to give guidance to hospitals and universities who have their own IRBs/RECs on the requirements needed by the Lebanese Ministry of Public Health to be officially authorized to be allowed to review and oversee the ethical aspects of research that involve human subjects. Hospitals and centers who do not have their own IRBs/RECs are allowed to be affiliated with authorized IRBs/RECs per the requirements of the Ministry.
- Director General Memo No.119 Date 28/11/2019
- Minister Decision No.141 Date 27/1/2016
- IRB Evaluation Report
- WHO Guidelines
List of Authorized IRBs
تؤكد وزارة الصحة العامة على جميع المستشفيات و المراكز التي ترغب باجراء دراسات سريرية و ابحاث تستهدف الانسان بضرورة الالتزام بالقرار رقم 141/1 تاريخ 27 كانون الثاني 2016 لجهة التقدم بطلب لوزارة الصحة العامة للاعتراف رسمياً بلجنة اخلاقيات الابحاث Institutional Review Board (IRB)التابعة لها او التعاقد مع مستشفى او مركز لديه IRB معترف بها رسمياً من الوزارة.
و تود وزارة الصحة العامة التذكير بان المهلة المعطاة لتقديم المستندات المطلوبة تنتهي في 27 كانون الثاني 2017, و بناءاً عليه لن توافق الوزارة على اي دراسة سريرية خارج هذا الاطار بعد هذا التاريخ.
تجدون ربطاً لائحة الجامعات والمستشفيات التي قدمت طلبات للإعتراف بلجان الأخلاقيات للتجارب السريرية التابعة لها والطلبات التي تمت دراستها و الطلبات التي تمت الموافقة عليها.
و تود وزارة الصحة العامة التذكير بان المهلة المعطاة لتقديم المستندات المطلوبة تنتهي في 27 كانون الثاني 2017, و بناءاً عليه لن توافق الوزارة على اي دراسة سريرية خارج هذا الاطار بعد هذا التاريخ.
تجدون ربطاً لائحة الجامعات والمستشفيات التي قدمت طلبات للإعتراف بلجان الأخلاقيات للتجارب السريرية التابعة لها والطلبات التي تمت دراستها و الطلبات التي تمت الموافقة عليها.
C. Exportation of Biological Samples as part of clinical trials
This section is developed to give guidance to researchers and sponsors who wish to export biological samples (blood, urine, etc) to be tested outside the country as part of clinical trials protocols on the requirements needed to obtain the approval from the ministry.
This section is developed to give guidance to researchers and sponsors who wish to export biological samples (blood, urine, etc) to be tested outside the country as part of clinical trials protocols on the requirements needed to obtain the approval from the ministry.
- Director General Decree no.2257 Date 4/12/2015
- Director General Memo No.84 Date 12/9/2013
- Director General Memo No.72 Date 14/9/2012
- Application Form to be submitted
D. Lebanon Clinical Trials Registry (LBCTR)
The Lebanese Clinical Trials Registry (LBCTR) is an online register of clinical trials being undertaken in Lebanon. The LBCTR will include trials that target humans; from the full spectrum of therapeutic areas of pharmaceuticals, surgical procedures, preventive measures, lifestyle, devices, treatment and rehabilitation strategies and complementary therapies.
The LBCTR will allow registration for interventional as well as observational studies.
- The MOPH is the owner and the sole manager of the LBCTR.
- All details of trials registered on the LBCTR will be made publicly available.
- The registration of Interventional studies will be mandatory and observational studies will be voluntary.
- The registration of studies is free of charge.
- The responsibility for registration lies with the sponsor.
- The sponsor is defined as: an individual, company or institution or organization which takes responsibility for the initiation, management and/or financing of a clinical trial.
- It is the sponsor's responsibility to ensure that the information submitted is accurate and up-to-date.
Sitemap 
© Copyrights reserved to Ministry of Public Health 2025